EG 01377)
|
|
- CAS号:
- 2227996-00-9
- 英文名:
- EG 01377)
- 英文别名:
- EG 01377);EG01377 free base;EG01377
(EG-01377;L-Arginine, N2-[[3-[[[5-[4-(aminomethyl)phenyl]-2,3-dihydro-7-benzofuranyl]sulfonyl]amino]-2-thienyl]carbonyl]-
- 中文名:
- EG 01377)
- 中文别名:
- 化合物 T11154
- CBNumber:
- CB74844748
- 分子式:
- C26H30N6O6S2
- 分子量:
- 586.68
- MOL File:
- 2227996-00-9.mol
|
|
|
EG 01377)化学性质
-
密度:
-
1.56±0.1 g/cm3(Predicted)
-
|
-
储存条件:
-
Store at -20°C
-
|
-
溶解度:
-
Soluble in DMSO
-
|
-
酸度系数(pKa):
-
3.40±0.21(Predicted)
-
|
EG 01377)性质、用途与生产工艺
EG01377 是有效的、可生物利用的和选择性的 neuropilin-1 (NRP1) 抑制剂,Kd 值为 1.32 μM,对 NRP1-a1 和 NRP1-b1 的 IC50 值均为 609 nM。EG01377 具有抗血管生成,抗迁移及抗肿瘤等活性。
IC50: 609 nM (NRP1-a1 and NRP1-b)
Kd: 1.32 μM (NRP1-b1)
EG01377 (3-30 μM; 30 minutes) inhibits vascular endothelial growth factor A (VEGF-A) stimulated tyrosine phosphorylation of VEGF-R2/KDR.
EG01377 (30 μM) is able to significantly reduce HUVEC cell migration in response to VEGFA.
EG01377 (30 μM; 5 days) can delay the VEGF-induced wound closure.
EG01377 (30 μM) reduces network area, length, and branching points.
EG01377 (30 μM; 7 days) reduces VEGF-induced angiogenesis.
EG01377 (30 μM; 7 days) in combination with VEGFA reduces A375P (malignant melanoma) spheroid outgrowth.
EG01377 (500 nM; 2 hours) blocks the production of transforming growth factor beta (TGFβ) by Nrp1
+
regulatory T-cell SMAD3/AKT (Tregs) in the presence of tumor cell-derived factors.
Western Blot Analysis
Cell Line:
|
Human umbilical vein endothelial cells (HUVECs)
|
Concentration:
|
3, 10, 30 μM
|
Incubation Time:
|
30 minutes
|
Result:
|
Inhibited VEGF-A stimulated tyrosine phosphorylation of VEGF-R2/KDR with an IC
50
of 30 μM.
|
EG01377 (2 mg/kg; i.v.) exhibits an encouraging half-life of 4.29 h, sufficient to sustain once per day dosing in mice.
Animal Model:
|
6–8 week-old BABL/c female mice
|
Dosage:
|
2 mg/kg (Pharmacokinetic Analysis)
|
Administration:
|
I.v. administration
|
Result:
|
The half time (T
1/2
) of 4.29 h.
|
EG 01377)
上下游产品信息
上游原料
下游产品
2227996-00-9, EG 01377) 相关搜索:
- 化合物 T11154
- 2227996-00-9
- L-Arginine, N2-[[3-[[[5-[4-(aminomethyl)phenyl]-2,3-dihydro-7-benzofuranyl]sulfonyl]amino]-2-thienyl]carbonyl]-
- EG01377 free base
- EG01377
(EG-01377
- EG 01377)